Predicting sPTB Early: What Do We Do Now?

Article

The objective if this discussion is to look at some of the implications of having an objective predictor. What do we do differently? In what ways can this make a greater difference in our fight against preterm birth? We also need to address some of the uncertainties that exist when we know a woman is at risk for preterm birth.

Predicting sPTB Early: What Do We Do Now?


With the tools available to us today, physicians are unable to predict the large majority of women who will eventually deliver preterm. Now we have a proteomic predictor – which also provides the beginning of greater understanding of pathways.
 
The objective if this discussion is to look at some of the implications of having an objective predictor. What do we do differently? In what ways can this make a greater difference in our fight against preterm birth? We also need to address some of the uncertainties that exist when we know a woman is at risk for preterm birth.
 

 

 

Recent Videos
Lauren Streicher, MD
JoAnne Pinkerton, MD, FACOG, NCMP
Nannette Santoro, MD
Lauren Streicher, MD
March of Dimes reports increase in maternity care desert prevalence | Image Credit: marchofdimes.org.
Evaluating a miniature robotic device for hysterectomy | Image Credit: linkedin.com.
Discussing low-dose aspirin use for preeclampsia prevention | Image Credit: komodohealth.com
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
Related Content
© 2024 MJH Life Sciences

All rights reserved.